Dr. Luke J. Mountjoy, DO

Dr. Mountjoy practices at HealthONE Clinic Services - Oncology Hematology in Denver, Colorado.

Dr. Mountjoy's NPI, 1447665906, was assigned on June 24, 2014. Dr. Mountjoy graduated from Des Moines University of Osteopathic Medicine and Health Sciences in 2014. Dr. Mountjoy holds Colorado license DR0062549.

Dr. Mountjoy's primary practice is HealthONE Clinic Services - Oncology Hematology, at 1721 E 19th Ave, Denver, CO 80218 in Denver County. The practice phone is (720) 754-4800.

Dr. Mountjoy's primary practice is HealthONE Clinic Services - Oncology Hematology in Denver, Colorado. Dr. Mountjoy is also affiliated with HCA HealthONE Presbyterian St. Luke's. The medical group on file is HCA HealthONE Physicians. Dmand AI also links Dr. Mountjoy to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mountjoy practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mountjoy's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Mountjoy's licenses on file in 3 states: Colorado, Arizona and Iowa.

Dmand AI lists anemia, chronic anemia, electrolyte disorders, insomnia, neutropenia and sepsis among the conditions Dr. Mountjoy treats.

CMS data shows 6,369 Medicare services from Dr. Mountjoy across 13 procedure codes in 2024, for 256 Medicare patients. Medicare paid $233,695 for them. Every service was in an office.

CMS counts 256 Medicare patients who saw Dr. Mountjoy in 2024. The largest group is 65 to 74, with 156 patients. 69% of them have high blood pressure, and 64% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mountjoy's median patient age at 67, with 43% women.

In 2024, Dr. Mountjoy wrote 1,241 Medicare Part D claims for 124 patients. 68% of them were for generic drugs. CMS names the drug for 897 of them, across 30 drugs with 11 or more claims each, at $2,525,687 in total drug cost. In 2023, CMS named 742 claims across 35 drugs.

Dr. Mountjoy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mountjoy as offering telehealth.

Dmand AI links 16 papers to Dr. Mountjoy, published from 2017 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation Conditioning and Immunotherapy, Adoptive. Dr. Mountjoy has published most often in Am J Clin Oncol. Dr. Mountjoy's most frequent co-authors are Daniel H. Ahn, DO, Mitesh J. Borad, MD and Nandita Khera, MD.

CMS Open Payments shows 53 general payments to Dr. Mountjoy from 12 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 99% of the total. Celgene Corporation paid the most, $420. It also lists 1 research payment totaling $550 in 2025, naming 1 clinical trial.

Dr. Mountjoy graduated from Des Moines University of Osteopathic Medicine and Health Sciences in 2014.

Dr. Mountjoy is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.